| Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... Circulation 129 (3), 399-410, 2014 | 21559* | 2014 |
| Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... Circulation 131 (4), 434-441, 2015 | 15446 | 2015 |
| Heart disease and stroke statistics—2018 update: a report from the American Heart Association EJ Benjamin, SS Virani, CW Callaway, AM Chamberlain, AR Chang, ... Circulation, 2018 | 6492 | 2018 |
| A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee The Lancet 348 (9038), 1329-1339, 1996 | 5984 | 1996 |
| Heart disease E Braunwald | 4910 | 1988 |
| An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction Gusto Investigators New England Journal of Medicine 329 (10), 673-682, 1993 | 4278 | 1993 |
| Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report P Brugada, J Brugada Journal of the American College of Cardiology 20 (6), 1391-1396, 1992 | 4139 | 1992 |
| Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial SR Steinhubl, PB Berger, JT Mann III, ETA Fry, A DeLago, C Wilmer, ... Jama 288 (19), 2411-2420, 2002 | 4034* | 2002 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3391 | 2006 |
| A controlled trial of arthroscopic surgery for osteoarthritis of the knee JB Moseley, K O'Malley, NJ Petersen, TJ Menke, BA Brody, ... New England Journal of Medicine 347 (2), 81-88, 2002 | 2958* | 2002 |
| Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association HP Adams Jr, RJ Adams, T Brott, GJ Del Zoppo, A Furlan, LB Goldstein, ... Stroke 34 (4), 1056-1083, 2003 | 2950* | 2003 |
| ISIS-4 SCDH TRIAL Lancet 345 (8951), 669-85, 1995 | 2932* | 1995 |
| Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty Epic Investigators New England Journal of Medicine 330 (14), 956-961, 1994 | 2845 | 1994 |
| American heart association statistics committee and stroke statistics subcommittee EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... Heart disease and stroke statistics-2017 update: a report from the American …, 2017 | 2758* | 2017 |
| Risk of cardiovascular events associated with selective COX-2 inhibitors D Mukherjee, SE Nissen, EJ Topol Jama 286 (8), 954-959, 2001 | 2319 | 2001 |
| Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization Epilog Investigators New England Journal of Medicine 336 (24), 1689-1697, 1997 | 2022 | 1997 |
| The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction GUSTO Angiographic Investigators New England Journal of Medicine 329 (22), 1615-1622, 1993 | 2020 | 1993 |
| Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum A Ahmad, P Mukherjee, S Senapati, D Mandal, MI Khan, R Kumar, ... Colloids and surfaces B: Biointerfaces 28 (4), 313-318, 2003 | 1872 | 2003 |
| Prevalence of conventional risk factors in patients with coronary heart disease UN Khot, MB Khot, CT Bajzer, SK Sapp, EM Ohman, SJ Brener, SG Ellis, ... Jama 290 (7), 898-904, 2003 | 1845 | 2003 |
| Chitin chemistry GAF Roberts Macmillan International Higher Education, 1992 | 1689 | 1992 |
